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INTRODUCTION:  Follicular  carcinoma  of  thyroid  usually  behaves  in  an  indolent  manner  with  low
metastatic  potential.  Distant  metastases  as  initial  presentation  is  rare  in follicular  carcinoma;  especially
in  young  patients.
PRESENTATION  OF  CASE:  We  report  the  clinical,  pathological  features  and  the  management  of  three  dif-
ferent  cases  of follicular  carcinoma  of the  thyroid  with  unusual  presentations  at the  time  of diagnosis.
First  case  presented  as  thyroid  abscess,  second  case  with  a large  skull  swelling  in a pre-exiting  goiter  and
the  third  case  with  a swelling  in  the  sternum.
DISCUSSION:  Follicular  carcinoma  of  thyroid  is  the  second  category  of well-differentiated  thyroid  cancer
that constitutes  about  10%  of  all thyroid  malignancies.  Blood  borne  metastasis  is common  with  spread
to  lung,  bone  and  other  solid  organs.  In  less  than  10%  cases  of  follicular  carcinoma,  there  is evidence  of
lymphatic  involvement.  The  patients’  presentations  above  are  highly  unusual.
CONCLUSION:  Recognizing  these  cases  has  a signiﬁcant  impact  on  clinical  decision-making  and  prognosis
of  the  patients.  Treatment  in  these  patients  should  be individualized  and an alternative  therapeutic
approach should  be  considered.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Papillary (PTC) and follicular (FTC) thyroid carcinomas are fol-
icular cell-derived carcinomas. They are differentiated forms of
hyroid carcinoma and are characterized by slow growth and an
ndolent biological behavior. These cancers usually remain local-
zed in the thyroid gland. Follicular thyroid carcinoma is the
econd most common thyroid cancer after papillary carcinoma.
t accounts for 10–20% of all thyroid malignancies and is most
ften seen in patients over 40 years of age.1 The tumor usu-
lly presents as an asymptomatic solitary thyroid nodule. These
eoplasms tend to metastasize hematogenously, with lung and
one most commonly affected,2 while distant metastases at the
ime of diagnosis are reported in 11–20% of patients.3 Less than
% of these cases are seen in patients younger than 45 years
f age.4 There have been a few case reports of follicular carci-
oma causing unusual bony metastases, such as skull,5 mandible,6
axilla,7 spine,8 and orbit.9 Sometimes, the metastatic focus may
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be the presenting feature. When combined with distant especially
widespread metastases, the quality of life is compromised and the
overall survival rate signiﬁcantly decreases. Hence management
of follicular carcinoma requires special attentions and knowledge
about its metastatic potential and its effect. Eighty percent of
differentiated thyroid carcinoma (DTC) patients respond to total
thyroidectomy, radioiodine-131 (131I) ablation and levothyroxine
suppression treatment.10 We  discuss here the unusual presenta-
tions of these cases of follicular thyroid carcinoma and their difﬁcult
management.
2. Case series
We  have described three cases of follicular Carcinoma of thyroid
with unusual presentations. First case presented as thyroid abscess,
second case presented with a large skull swelling in a pre-exiting
goiter, and the third case presented with a swelling in the ster-
num. The ﬁrst case was  a 25 year old lady having a pre-existing
goiter for 5 years (Fig. 1). She was diagnosed as follicular ade-
noma by ﬁne needle aspiration cytology (FNAC) 2 years back but
refused for surgery. She came with sudden onset of pain, swelling,
fever with chill & rigor, redness, erythema and tenderness over the
swelling and dysphagia. She was  treated with a complete course
of antibiotic based on culture sensitivity. On ultrasonography
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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nly cystic component was found and subsequently underwent
emithyroidectomy which came out to be follicular carcinoma of
hyroid. Second Case was a 40 yr old lady, had a pre-existing Goiter
or last 10 years. She was on regular follow up by an endocri-
ologist. She developed a swelling on the left parietal region of
he skull for last one year, gradually increasing in size for which
he reported to us. On examination, a globular hard swelling of
ize about 2 cm × 4 cm × 4 cm situated on left parietal bone of her
kull (Fig. 2a). An incisional biopsy was performed. The histopatho-
ogical examination revealed thyroid follicles ﬁlled with colloid
aterial which is positive for PAS stain. The cells surrounding the
ollicles were intensely positive for thyroglobulin. The interpreta-
ion was metastatic follicular carcinoma of the thyroid. X-ray and
agnetic resonance imaging (MRI) of skull showed bone destruc-
ion with intracerebral extension (Fig. 2b,d,e). She underwent total
hyroidectomy and the histopathology of the specimen showed fol-
icular carcinoma with lymphovascular invasion (Fig. 2c). Then the
atient was referred to radiotherapy department for radioiodine
herapy. Third case was a 45 year old lady presented with a Solitary
hyroid nodule (STN) on left lobe of thyroid, left hemithyroidec-
omy was done based upon FNAC report as follicular adenoma. Two
ears later patient presented with a swelling on right lobe of thy-
oid with a swelling on the sternum (Fig. 3). Core needle biopsy
rom the sternal growth comes out as metastatic follicular carci-
oma. She underwent completion thyroidectomy with radioiodine
herapy.
. Result
First case was a minimally invasive follicular carcinoma and
emithyroidectomy was appropriate extent of surgical excision.
he was on suppressive dose of Thyroxine and doing well in 3 years
ollow up. In the 2nd case after total thyroidectomy and radioio-
ine treatment the skull swelling disappeared, on follow up of 1ma of thyroid presenting as thyroid abscess.
year she had hemoptysis. Computed tomography (CT) scan of chest
showed bilateral chest metastatic nodules. The patient is now on
chest external beam radiation therapy (EBRT). In the third case
after total thyroidectomy and radioiodine therapy there was no
recurrence of the tumor on follow up of 2 years.
4. Discussion
Follicular carcinoma is the second most prevalent of the thy-
roid carcinomas with an incidence of approximately 10–15%. Blood
borne metastasis is common with spread to lung, bone and other
solid organs. In less than 10% cases of follicular carcinoma, there is
evidence of lymphatic involvement.11 Patients with differentiated
thyroid carcinoma (DTC) have a 10-year survival rate of 80–95%.
However, when distant metastases are present, the overall 10-year
survival rate is 40%.12 The patients’ presentations above are highly
unusual.
Thyroid abscess and acute supporative thyroiditis are not
common, presenting only 0.1–0.7% of surgically treated thyroid
pathologies.13 Infection of the thyroid gland are rare due to its
isolated anatomic location, ﬁbrous capsule, rich blood supply, gen-
erous lymphatic drainage, and high content of iodine. However,
various factors like congenital pyriform sinus, thyroid/neck injury,
blood-borne infections, surrounding infections and intrinsic gland
pathology like nodular goiter, thyroid cyst, and papillary thyroid
cancer may predispose to suppurative thyroiditis.14 Infection in
pre-existing thyroid pathology may  present with localized thyroid
abscess. In the ﬁrst case, the underlying pathology was solitary thy-
roid nodule and FNAC revealed follicular adenoma. After 2 years,
the patient presented with thyroid abscess. Hemithyroidectomy
was done and biopsy showed follicular carcinoma.
Bone metastases from DTC occur in 2–13% of patients. When
bone metastases are present, the overall survival at 10 years
was reported to range from 13 to 21%.15 The study of Durante
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rig. 2. (A) Second case, a 40 yr old lady with metastasis over skull bone (B)–(D) CT
he  scalp and intracranially. (E) Histopathology showing follicular carcinoma with l
t al. (2006) found 44% of bone metastases in 444 metastatic DTC
atients. They are more frequent in Follicular thyroid carcinoma
7–28%) compared with Papillary thyroid carcinoma (1.4–7%). The
ones most often involved in metastasis of follicular carcinoma are
he long bones, such as the femur and ﬂat bones, particularly the
elvis and sternum.16 It is not unusual for a pathological break of
 long bone to be the ﬁrst clinically signiﬁcant manifestation of
ollicular thyroid carcinoma. The second case was  being followed
p by an endocrinologist who aggressively worked up the patient
or the benign lesions of the thyroid over a period of two-years, but
ad signiﬁcant metastasis in the left parietal region of the skull that
easured about 2 cm × 4 cm × 4 cm in size. Research indicates thatreatment with radioactive iodine improves survival for patients
ith thyroid cancer that has spread to nearby lymph nodes or to
istant locations in the body.17 The patient underwent total thy-
oidectomy followed by radioiodine therapy.
Fig. 3. Third case, a 45 year old lady with follicula showing large fronto-parietal mass eroding through the skull, and extending into
ovascular invasion.
The staging of follicular thyroid carcinoma is differentiated from
the standpoint of the age of the patient. There are two categories:
older than 45 years of age and younger than 45 years of age. Staging
of patients who  are younger than 45 years of age is quite simple; if
the carcinoma is conﬁned to only the thyroid with no lymph node
involvement or metastasis, it is stage I. In our patient, who had dis-
tant metastasis, the carcinoma would be considered stage II. This
method of staging is the tumor, node, metastasis method (TNM
method) and is the ofﬁcial method of staging adopted by the Amer-
ican Joint Commission on Cancer. In cases of metastatic disease to
lung and/or bone, adverse prognostic factors are said to include
multiplicity of sites, older patient age at the time of discovery of
the metastases, and absence of radioactive iodine uptake by the
metastases.18
The extent of metastatic disease to bone and its response to
radioactive iodine are associated with survival.19 A retrospective
r carcinoma thyroid with sternal metastasis.
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tudy evaluated therapeutic outcome, total administered radioio-
ine activities, and side effects (blood count alterations grades I–IV,
HO  classiﬁcation, and acute leukemia) in 107 patients with initial
one metastases. This study concluded that initial bone metastases
n selected DTC patients up to 45 years and especially in those
ith less than three bone metastases can be treated with curative
ntent.20
. Conclusion
Although the incidence of papillary thyroid carcinoma is much
igher than of follicular carcinoma, the later accounts for more
eaths. Follicular carcinoma differs from papillary in that it occurs
t an older age, exhibits hematogenous spread rather than lym-
hatic dissemination, and has a more aggressive behavior. So total
hyroidectomy with adjuvent radioiodine therapy remains the
tandard of treatment for follicular carcinoma thyroid. Dissemi-
ated metastases from follicular carcinoma at the time of diagnosis
n a young patient remain exceedingly rare. Even if it is advanced
nd metastatic, can be managed adequately with proper modalities
f treatment.
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